At a glance
- Originator Roche Palo Alto LLC
- Class Antidementias; Neuroprotectants
- Mechanism of Action Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cognition disorders; Irritable bowel syndrome
Most Recent Events
- 25 Aug 1998 No-Development-Reported for Cognition disorders in USA (Unknown route)
- 25 Aug 1998 No-Development-Reported for Irritable bowel syndrome in USA (Unknown route)
- 11 Jun 1996 Preclinical development for Cognition disorders in USA (Unknown route)